Responses
Drug information and pharmacotherapy
DI-010 Factors influencing the appearance of haematological and thyroid adverse effects in patients with hepatitis C virus genotype 1 treated with telaprevir/boceprevir plus peg-interferon and ribavirin
Compose a Response to This Article
Other responses
No responses have been published for this article.